Ausverkauft
faceLITE beauty boosting LED face mask
€349,99
SUMMARY
FaceLITE uses clinically proven wavelengths of light to instantly energize skin cells for a natural revitalising boost to dull, tired, ageing skin
- faceLITE combines optimised red and infrared light to give long-lasting results, stimulating the skin’s natural rejuvenation processes in a unique, quick, and easy full facial treatment that you do at any time while relaxing, reading, or even working
-
faceLITE can be combined with Hydrogel mask treatments for enhanced results and benefits. (optional / not included)
- Treats the whole face in just 10 minutes
- Comfortable, soft-fit mask
- Hypoallergenic
- Auto-Timer
- Flat, portable and travel friendly
- USB chargeable
- Clinically proven
- FDA Cleared
Due to the loss of collagen and elastic tissue as we age, the skin becomes thinner and drier and develops sags and wrinkles. Aging skin is also much more susceptible to the development of brown spots and pigmentation. Additionally, the skin's dermis can lose from 20 to 80% of its thickness during the aging process. faceLITE™ uses two proven wavelengths of light; 633nm (red light) and 830nm (near-infrared light). These wavelengths have been shown in clinical studies to stimulate collagen and elastin production cells through a process called photobiomodulation. faceLITE has been designed to deliver light directly to the skin, ensuring that the maximum amount of light hits its cellular targets and is not wasted.
faceLITE combines optimised red and infrared light to give long-lasting results, stimulating the skin’s natural rejuvenation processes in a unique, quick, and easy full facial treatment that you do at any time while relaxing, reading, or even working. Simply wear the soft, hypoallergenic mask for 10 minutes each day to see how your skin is transformed in just a few short treatments.
faceLITE is FDA cleared.
faceLITE can be combined with Hydrogel mask treatments for enhanced results and benefits. (optional / not included)
FREQUENTLY ASKED QUESTIONS
How does faceLITE LED treatment work?
faceLITE uses proven wavelengths of light; 633nm red light and 830nm or near infra-red light. These wavelengths have been shown in studies to stimulate collagen and elastin production and help to improve blood flow and tissue oxygenation through a process called photobiomodulation. These effects help skin cells absorb topical skincare products more effectively and help reverse the effects of the aging process.
faceLITE has been designed to deliver light directly to the skin, ensuring that the maximum amount of light hits its cellular targets and is not wasted.
Is it safe?
faceLITE has been tested and is compliant to international safety standards. Since the mask doesn’t cover the eyes; eye protection isn’t necessary.
Is the faceLITE treatment painful?
No pain should be felt whilst using faceLITE. The light penetrates the skin and stimulates the cells to work in a natural way. faceLITE is non-invasive and there is no heat and therefore the treatment is completely pain-free.
Who is suitable for faceLITE?
DO NOT use faceLITE if you are taking any medication that can cause photosensitivity, have a photosensitive disorder or are pregnant or breastfeeding. Photosensitivity (sensitization to light) is a common side effect of various medications and some herbal remedies.
Since faceLITE generates no heat, most people are suitable but there is a list of contraindications that should be referred to by anyone who is thinking of having a faceLITE treatment.
If you are unsure, please speak with your healthcare provider.
What results can I expect?
Fine Lines & Wrinkles
After 3 treatments per week for 4 weeks; up to 41% reduction of wrinkles, with reduction in redness and softer, smoother, rehydrated skin.
Improved Skin Texture
After 1 Treatment per week for 4 weeks; 41% improvement in skin texture and smoothness, showing hydration and cell turnover increase and after 3 treatments per week for 4 weeks 95% showed an improvement in texture, firmness and skin tone.
Increased Blood Flow
After 3 treatments per week for 4 weeks; 95% confirmed skin looked brighter and plumper.
Tissue Oxygenation
faceLITE uses proven wavelengths of light; 633nm red light and 830nm or near infra-red light. These wavelengths have been shown in studies to stimulate collagen and elastin production and help to improve blood flow and tissue oxygenation through a process called photobiomodulation.
*Tested on over 100 patients in Independent clinical studies, peer reviewed published papers, with supported claims that are proven statistically to be significant.
How often do I need to use faceLITE?
For best results we recommend that you treat for 3-5 days a week for a minimum of 4 weeks.
We recommend maintenance treatments to ensure you keep your skin looking younger and fresher.
Do all of the the LED's need to be in contact with the skin?
In order for the mask to be fitted securely you will notice most that it makes contact with the forehead. The mask is designed to bring the LEDs into close proximity to the skin. Due to the contours of the face this does vary between locations which is quite normal. The actual energy delivered for the two wavelengths is set to take this into account. Most importantly the proving clinical studies have been done with this exact mask design to ensure the products performance.
Can I use faceLITE with my own skincare?
faceLITE has been proven in trials to greatly improve skin parameters such as hydration, texture and pigmentation. faceLite improves tissue oxygenation and blood flow and therefore absorption of skin care will be greatly improved.
faceLITE is compatible with most normal skincare routines
Can I combine faceLITE with other aesthetic treatments?
Yes, faceLITE can be combined with more invasive treatments such as botox, peels, injectables and laser resurfacing; it can help in the healing process and help to reduce bruising and swelling due to its anti-inflammatory properties
Can I use the faceLITE when pregnant?
No, you should not use the faceLITE if you are pregnant, planning on becoming pregnant or breastfeeding. The faceLite LED system has NOT been tested on pregnant or breast-feeding women and therefore the risk to the feotus, neonate or pregnant women is unknown.
Can I get sunburn from using the faceLITE?
No. There is zero / no UV component to the light source.
What is the faceLITE advantage?
- Uses clinically proven technology and proven wavelengths of light.
- Flexible patent technology
- Soft, comfortable silicon that contours to your face. Completely portable – take faceLITE anywhere
- Designed and built to International medical standards using medical grade components
Contraindications:
- DO NOT use the faceLITE™ LED system if you suffer from lupus erythematosus, photosensitive eczema or albinism.
- DO NOT use the faceLITE™ LED system if you suffer from any photosensitive disorder (sensitization to light).
- DO NOT use the faceLITE™ LED system if you are taking any medication that can cause photosensitivity. Always check your medication or consult your doctor for any photosensitivity side effects.
- DO NOT use faceLITE™ LED mask if you suffer from light-induced headaches.
- DO NOT use faceLITE™ LED mask if you suffer from any genetic conditions of the eye.
Photosensitivity is a common side effect of various medications.
These can include certain antibiotics, chemotherapy drugs, and diuretics. If you are unsure about any medication you may be taking consult your healthcare provider.
Other substances not listed above can also cause photosensitivity.
Common examples of these substances are:
St John's wort, coal tar, deodorants, antibacterial soaps, artificial sweeteners, naphthalene (mothballs), petroleum products, brightening agents found in laundry detergent, and cadmium sulphide (a chemical injected into the skin during tattooing).
There are some instances in which the faceLITE™ / DécoLITE™ photofacial may prove unsuitable for an individual. Certain medical conditions or drugs may mean that an individual is unsuitable for the treatment.
Precautions due to drug induced photosensitivity
If you are taking any of the drugs listed below, please read the comments section of the table carefully.
|
Drug Type |
Specific Group or Common Name |
Comments |
|
Anti-Arthritic |
Gold 50 or Ridaura |
If YES, the treatment cannot be administered |
|
Anti- Arthritic or Immunosuppressant |
Azathioprine (Imuran, Azasan) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
Anti Arrythmic |
Amiodarone (Cordarone, Pacerone), Aratac |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
|
Quinidine |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 10/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Antibiotics |
Fluoroquinolones: Ciprofloxacin (Cipro), Levofloxacin (Levaquin), Lomefloxacin (Maxaquin),Norfloxacin (Noroxin), Ofloxacin (Floxin) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
Anti-Cancer |
Bexarotene (Targretin), Capecitabine (Xeloda), Dacarbazine (DTIC), Epirubicin (Ellence), Fluorouracil (5-FU), Interferon alfa (Intron A, Alferon-N), Methotrexate (Mexate), Pentostatin (Nipent), Procarbazine (Matulane), Tretinoin, oral (Vesanoid), Vinblastine (Velban, Velbe) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is between a 1 /100 and 5/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Anticonvulsants |
Carbamazepine (Tegretol), Felbamate (Felbatol), Gabapentin (Neurontin), Lamotrigine (Lamictal), Oxcarbazepine (Trileptal), Topiramate (Topamax), Valproic acid (Depakene) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Antifungals |
Flucytosine (Ancobon), Griseofulvin (Fulvicin, Gris-PEG), Terconazole (Terazol) Voriconazole (VFEND) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
Antihistamines |
Cetirizine (Zyrtec), Diphenhydramine (Benadryl), Loratadine (Claritin), Promethazine (Phenergan) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
Antihypertensives |
Captopril (Capoten), Diltiazem (Cardizem, Tiazac), Enalapril (Vasotec), Nifedipine (Procardia), Sotalol (Betapace) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
Antimalarial |
Chloroquine (Aralen), Hydroxychloroquine (Plaquenil), Pyrimethamine (Daraprim), Pyrimethamine/sulfadoxine (Fansidar), Quinine |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days |
|
Antipsychotics |
Phenothiazines: Chlorpromazine (Thorazine), Fluphenazine (Prolixin), Perphenazine (Trilafon), Prochlorperazine (Compazine), Thioridazine (Mellaril), Trifluoperazine (Stelazine) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is between a 2/100 and 3/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Antiretroviral |
Ritonavir (Norvir), Saquinavir (Fortovase,Invirase), Zalcitabine (Hivid) |
If YES, it is at the discretion of the client as to whether they commence the treatment. If YES, it is at the discretion of the client as to whether they commence the treatment. There is approximately a 2/100 chance of a light reaction. |
|
Antiviral |
Amantadine (Symmetrel), Acyclovir (Zovirax) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is approximately a 1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Cardiovascular |
Thiazide diuretics: Bendroflumethiazide (Corzide), Chlorthalidone (Thalitone), Hydrochlorothiazide (Microzide), Hydroflumethiazide (Diucardin), Indapamide (Lozol), Methyclothiazide (Enduron), Metolazone (Zaroxolyn), Polythiazide (Renese) |
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days. |
|
Lipid regulators Other |
Fenofibrate (Tricor) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 10/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Non-steroidal anti-inflammatory (NSAIDs) Analgesics |
Diclofenac (Voltaren, Cataflam), Naproxen (Anaprox) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a <1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 1 day, then the treatment can be administered. |
|
Sedatives |
Alprazolam (Xanax), Chlordiazepoxide (Librium), Zaleplon (Sonata), Zolpidem (Ambien |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is a 1/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Skin agents (acne) |
Isotretinoin (Accutane, Roaccutane) Tretinoin topical (Renova, Retin-A) Tazarotene (Tazorac) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is between a 5/100 and a 10/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
|
Skin agents (hair) |
Coal tar, Minoxidil (Rogaine) |
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment. There is <0.5/100 chance of a light reaction. If the client has stopped taking the medication for ≥ 5days then the treatment can be administered. |
Model: FCLT2
